CRP and cancer: Several systemic inflammatory biomarkers have been examined to predict prognosis in different types of cancer, including C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and modified Glasgow Prognostic Score [31,32,33].